| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/03/1998 | US5723315 Secreted proteins and polynucleotides encoding them |
| 03/03/1998 | US5723309 Production of subunits of soluble T cell receptors by co-transfection |
| 03/03/1998 | US5723287 Retroviral particle comprising fusion protein and nucleic acid; genetic engineering |
| 03/03/1998 | US5723128 Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides |
| 03/03/1998 | US5723127 Cancer therapy, vaccines; cell-mediated immune response enhancers |
| 03/03/1998 | US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| 03/03/1998 | US5723120 Method of treating an IL-6 related disease with interleukin-6 receptor antagonists |
| 03/03/1998 | US5723118 Therapeutic agents which are antagonists or partial agonists of human interleukin 4 |
| 03/02/1998 | CA2213690A1 Use of retinoid in preparing a medication to treat disorders related to overexpression of vegf |
| 02/26/1998 | WO1998008101A1 Materials and methods for detection and treatment of immune system dysfunctions |
| 02/26/1998 | WO1998007880A1 Human endokine alpha |
| 02/26/1998 | WO1998007859A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007855A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007702A1 Diamide compounds and drugs containing the same |
| 02/26/1998 | WO1998007694A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 02/26/1998 | WO1998007444A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 02/26/1998 | WO1998007439A1 Method of inhibiting the release of bioactive il-1 |
| 02/26/1998 | WO1998007436A1 Treatment of autoimmune diseases |
| 02/26/1998 | WO1998007418A1 Il-8 receptor antagonists |
| 02/26/1998 | WO1998007321A1 Method for inhibiting the expression of fas |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/26/1998 | WO1997038966A3 Cytoprotective compounds |
| 02/26/1998 | CA2264200A1 Human endokine alpha |
| 02/26/1998 | CA2264192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2264178A1 Method for inhibiting the expression of fas |
| 02/26/1998 | CA2264070A1 Method of inhibiting the release of bioactive il-1 |
| 02/26/1998 | CA2264064A1 Imidazole compounds, compositions and use |
| 02/26/1998 | CA2263192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2259310A1 Materials and methods for detection and treatment of immune system dysfunctions |
| 02/25/1998 | EP0825186A1 2-Aminobenzazepine derivatives and their use for the treatment of immunosuppression |
| 02/25/1998 | EP0824917A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis |
| 02/25/1998 | EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque |
| 02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |
| 02/25/1998 | EP0824588A1 Il-6 activity inhibitor |
| 02/25/1998 | EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/25/1998 | EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 02/25/1998 | EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use |
| 02/25/1998 | EP0824538A1 Saccharopeptides and derivatives thereof |
| 02/25/1998 | EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 02/25/1998 | EP0824523A1 Nitric oxide synthase inhibitors derived from cyclic amidines |
| 02/25/1998 | EP0824360A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins |
| 02/25/1998 | EP0824358A1 Acellular pertussis vaccines and methods of preparation thereof |
| 02/25/1998 | EP0824355A1 Mistletoe extract and method |
| 02/25/1998 | EP0713490B1 C-22 ring stabilized rapamycin derivatives |
| 02/25/1998 | EP0581916B1 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
| 02/25/1998 | CN1174554A Rapamycin 42-oximes and hydroxylamines |
| 02/25/1998 | CN1174082A Method of using active peptide in strengthening animal's immunity and as vaccine adjuvant |
| 02/25/1998 | CN1174040A Compound antibacterial and antiviral veterinary medicine capable of raising immunity |
| 02/25/1998 | CN1037526C Method for producing kanglemycin C |
| 02/25/1998 | CN1037511C Prep. of 1 -( aralkyl amino-alkyl) imidazole compounds |
| 02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/24/1998 | US5721255 Useful for preventing pain, anxiety, migrane, schizophrenia, asthma, rheumatoid arthritis, fibrositis, or ulcerative colitis in mammal |
| 02/24/1998 | US5721240 9-substituted-8-unsubstituted-9-deazaguanines |
| 02/24/1998 | US5721119 Nucleic acid sequences |
| 02/19/1998 | WO1998007017A1 Method of determining variations in the properties of a sample |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006842A1 Mammalian cell surface antigens; related reagents |
| 02/19/1998 | WO1998006749A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 02/19/1998 | WO1998006747A2 Uses for wnt polypeptides |
| 02/19/1998 | WO1998006719A1 4-substituted beta-carbolines as immunomodulators |
| 02/19/1998 | WO1998006704A1 Arylalkanoyl pyridazines |
| 02/19/1998 | WO1998006703A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| 02/19/1998 | WO1998006429A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | WO1998006428A1 Mucosal immunogens for novel vaccines |
| 02/19/1998 | WO1998006416A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/19/1998 | WO1998006402A1 Treatment of the common cold or allergic rhinitis |
| 02/19/1998 | WO1998006399A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006397A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006394A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 02/19/1998 | WO1998006262A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006248A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 02/19/1998 | WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins |
| 02/19/1998 | WO1997042979A3 Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
| 02/19/1998 | DE19632549A1 Arylalkanoylpyridazine Arylalkanoylpyridazine |
| 02/19/1998 | CA2263550A1 Treatment of the common cold or allergic rhinitis |
| 02/19/1998 | CA2263388A1 Il-8 receptor antagonists |
| 02/19/1998 | CA2263195A1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 02/19/1998 | CA2263163A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/19/1998 | CA2262432A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | CA2262427A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/18/1998 | EP0824104A2 Immunoassay method |
| 02/18/1998 | EP0823913A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 02/18/1998 | EP0823906A1 Piperazino derivatives as neurokinin antagonists |
| 02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
| 02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
| 02/18/1998 | CN1173897A Eukaryotic initiation factor SA (eif-5A) mutants |
| 02/18/1998 | CN1173875A Process for preparing certain AZA Cyclohexapeptides |
| 02/18/1998 | CN1173818A Pharmaceutical preparations for tumour necrosis factor (TNF) inhibition |
| 02/18/1998 | CN1173497A Heterocycle-containing carbonic acid derivatives |
| 02/17/1998 | US5719184 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds |
| 02/17/1998 | US5719164 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates |
| 02/17/1998 | US5719127 Modified complement system regulators |
| 02/17/1998 | US5719123 Administering crystal form |
| 02/17/1998 | US5718900 Vaccines and methods for preventing and treating Fescue toxicosis in herbivores |
| 02/17/1998 | CA2001727C Organic compounds |
| 02/12/1998 | WO1998005787A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/12/1998 | WO1998005784A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | WO1998005783A1 A tumor necrosis factor related ligand |
| 02/12/1998 | WO1998005781A1 Secreted proteins and polynucleotides encoding them |